SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001377121-17-000007
Filing Date
2017-11-07
Accepted
2017-11-06 21:43:42
Documents
61
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx10-qq32017.htm 10-Q 1360864
2 EXHIBIT 31.1 ptgx10-qq3ex311.htm EX-31.1 14142
3 EXHIBIT 31.2 ptgx10-qq3ex312.htm EX-31.2 14154
4 EXHIBIT 32.1 ptgx10-qq3ex321.htm EX-32.1 11731
  Complete submission text file 0001377121-17-000007.txt   5712390

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ptgx-20170930.xml EX-101.INS 1057047
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptgx-20170930.xsd EX-101.SCH 44551
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptgx-20170930_cal.xml EX-101.CAL 66892
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptgx-20170930_def.xml EX-101.DEF 199598
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptgx-20170930_lab.xml EX-101.LAB 571500
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptgx-20170930_pre.xml EX-101.PRE 326098
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 171180931
SIC: 2834 Pharmaceutical Preparations